These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29079562)

  • 1. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
    Younis A; Younis A; Tzur B; Peled Y; Shlomo N; Goldenberg I; Fisman EZ; Tenenbaum A; Klempfner R
    Cardiovasc Diabetol; 2016 Oct; 15(1):149. PubMed ID: 27793156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
    Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
    Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis.
    Fisman EZ; Motro M; Tenenbaum A; Boyko V; Mandelzweig L; Behar S
    Am Heart J; 2001 Mar; 141(3):485-90. PubMed ID: 11231448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
    Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
    Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
    Bergman M; Chetrit A; Roth J; Dankner R
    Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease.
    Petersen JL; Yow E; AlJaroudi W; Shaw LK; Goyal A; McGuire DK; Peterson ED; Harrington RA
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):165-72. PubMed ID: 20179266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
    Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
    J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome predicts long-term mortality in subjects without established diabetes mellitus in asymptomatic Korean population: A propensity score matching analysis from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry.
    Won KB; Chang HJ; Han D; Sung J; Choi SY
    Medicine (Baltimore); 2016 Dec; 95(49):e5421. PubMed ID: 27930521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
    Bignotto M; Bianco E; Centofanti L; Russo A; Dei Cas M; Zermiani P; Morano C; Samartin F; Bertolini E; Bifari F; Berra C; Zuin M; Paroni R; Battezzati PM; Folli F
    Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E498-E511. PubMed ID: 39196799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Brismar K; Malmberg K; Mellbin L; Näsman P; Rydén L; Söderberg S; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2017 Mar; 14(2):77-87. PubMed ID: 28185529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study.
    Chen S; Li J; Li Q; Qiu Z; Wu X; Chen L
    BMC Cardiovasc Disord; 2019 Jan; 19(1):25. PubMed ID: 30674287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fasting glucose association with mortality in nondiabetic patients on maintenance peritoneal dialysis.
    Chen KH; Lin JL; Hung CC; Lin-Tan DT; Weng SM; Yen TH; Hsu CW; Yang CW
    Am J Med Sci; 2011 Apr; 341(4):312-7. PubMed ID: 21289510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up.
    Fisman EZ; Motro M; Tenenbaum A; Leor J; Boyko V; Mandelzweig L; Sherer Y; Adler Y; Behar S
    Eur J Cardiovasc Prev Rehabil; 2004 Apr; 11(2):135-43. PubMed ID: 15187817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.